|Study Type:||Phase I|
|Stage:||Primary analysis complete|
|Study Start Date:||NA|
|Study Made Public:||NA|
A Phase I clinical trial to evaluate immune response kinetics and safety of two different primes, adenoviral vector vaccine (VRC-HIV ADV014-00-VP) and DNA vaccine (VRC-HIVDNA009-00-VP), each followed by adenoviral vector boost in healthy, HIV-1 uninfected adults
HVTN 068 is a Phase I clinical trial to evaluate the safety and immunogenicity of VRC-HIV ADV014-00-VP (rAd5) alone and as a VRC-HIVDNA009-00-VP (DNA) prime / VRC-HIV ADV014-00-VP boost.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.